Newsletter Subject

4 Active stocks to trade before the weekend 🔥

From

elitetrade.club

Email Address

adam@elitetrade.club

Sent On

Fri, Jul 7, 2023 12:14 PM

Email Preheader Text

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarke

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Happy Friday! It's July 7th. I hope you have a great weekend. Let's get ready to trade! Markets 📈 Stocks sold off after a strong ADP jobs report raised the chances of another rate hike in July. The Dow lost 1.0%, while the S&P 500 and Nasdaq lost about 0.8%. The small-cap Russell 2K sold off for a 1.6% decline. Futures are trending lower in today's premarket, with S&P 500 contracts showing a loss of less than 0.1%. Sponsored [Hidden In Plain Sight: The Secret To Earning More!]( Hi, this is 10 time trading champion Chuck Hughes and for a long time even I was missing out on the strategy that took my account to a whole new level… In my new guide, Hidden Income Strategy, I'll reveal exactly how you could use this unique strategy to earn more–starting now! [Get a free copy HERE]( Premarket Highlights 🔎 📉 Meta's "Twitter Killer" Meets Mixed Reception Facebook & Instagram parent Meta [META] debuted its "Threads" app yesterday, and the premier was met with substantial criticism. Online tech commentators quickly pointed out that the app collects virtually every piece of accessible data from users' phones, and many early users are reporting the app censors content aggressively. Shares of Meta are down in today's premarket. What to Watch Today 👀 June Jobs Report Investors will be watching today's June employment report closely, especially after Thursday's ADP payrolls report sent the market lower. Ironically, a strong report could provoke a negative reaction in the market, as investors believe a strong job market gives the Fed more justification for raising rates higher in the months ahead. This report will undoubtedly have a major influence on today's trading session. Major Earnings 💰 Azz Inc. [AZZ] ... PM Economy 🏗 U.S. nonfarm payroll [Jun] ... 8:30a U.S. unemployment rate [Jun] ... 8:30a U.S. hourly wages [Jun] ... 8:30a Running Hot 🔥 Gainers - Bluejay Diagnostics [BJDX] >> +20.6% - Enservco [ENSV] >> +13.2% - Top Financial [TOP] >> +12.1% - Cadiz [CDZI] >> +10.7% Decliners - Abacus Life [ABL] >> (17.3%) - Healthcare Triangle [HCTI] >> (12.5%) - iMedia Brands [IMBI] >> (16.5%) - EdtechX [EDX] >> (16.5%) Rivian Automotive [RIVN] - Last Close: $21.62 An analyst upgrade is boosting shares of Rivian. This morning, analysts at Wedbush maintained their "outperform" rating on EV manufacturer, and raised its price target to $30 from $25. Analysts noted their confidence in Rivian's ability to achieve or improve upon its delivery targets. RIVN is up 4.3% on elevated trading volume in today's premarket, My Take: RIVN has been on an incredible run over the past week or so. Shares closed at $13.45 on June 26th, and it's on pace to add to its gains in today's session. Gorilla Technology [GRRR] - Last Close: $2.09 Gorilla Technology just landed a huge government contract. On Thursday evening, the IoT firm said it signed a three-year contract with Egypt's central government that could be worth more than $20 million. Gorilla will help the Egyptian government implement a "Smart Government Security Convergence" solution, according to the press release. It's the largest deal in Gorilla Tech's history, and it puts the company on pace to achieve profitability by the end of 2024. GRRR is one of today's top stocks with a 72.7% gain. My Take: One lucrative government contract can often lead to many more. If GRRR can successfully execute this deal, the company could draw interest from more government buyers. ZyVersa Therapeutics [ZVSA] - Last Close: $0.24 ZyVersa Therapeutics is trending after scoring a pivotal patent. This morning, news broke that the European Patent Office has approved a patent for one of the biopharma firm's key therapeutics. The EPO granted a patent covering ZyVersa's Cholesterol Efflux Mediator VAR 200 for use in diabetic nephropathy/diabetic kidney disease. The company says it expects VAR 200 to advance into its next phase of clinical trials in the fourth quarter. ZVSA is up 58.3% on the news. My Take: ZVSA is a long-shot biotech stock, but it could have some upside if it can successfully bring VAR 200 to market. T2 Biosystems [TTOO] - Last Close: $0.083 The Smart Money is taking an interest in T2 Bio. After Thursday's close, regulatory filings revealed that CR Group LP has taken a substantial position in the struggling biotech stock. According to the disclosure, CR Group purchased roughly 48 million shares of TTOO common stock on July 3rd. The firm now controls more than 10% of T2 Bio, and shares are reacting favorably to the news. TTOO is up 18.9% on active trading volume this morning. My Take: TTOO has performed terribly over the past six months, but maybe CR Group can help turn the company around. The fact that the firm spent so much money to acquire shares of this company implies that it sees some value here. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](

Marketing emails from elitetrade.club

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.